Godavari Biorefineries Limited
Clinical trials sponsored by Godavari Biorefineries Limited, explained in plain language.
-
New cancer pill tested in humans for first time
Disease control CompletedThis early-stage trial tested a new oral drug, MSP008-22, in 7 adults with advanced solid tumors (like breast or prostate cancer) that had spread. The main goal was to check safety and find the right dose, not to cure the cancer. Participants took a single dose and were monitored…
Phase: PHASE1 • Sponsor: Godavari Biorefineries Limited • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
New COVID-19 drug candidate passes first safety check in healthy volunteers
Knowledge-focused CompletedThis early-stage study tested a new oral drug called MSP008-22 in 64 healthy adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo, and researchers monitored for side effects. This study does not test whether the drug treats…
Phase: PHASE1 • Sponsor: Godavari Biorefineries Limited • Aim: Knowledge-focused
Last updated May 26, 2026 06:30 UTC